메뉴 건너뛰기




Volumn 2013, Issue 5, 2013, Pages

Eliciting adverse effects data from participants in clinical trials

Author keywords

[No Author keywords available]

Indexed keywords

ADVERSE DRUG REACTION; ARTICLE; CAUSALITY; CITATION ANALYSIS; DISEASE SEVERITY; ELICITATION METHOD; HUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SYSTEMATIC REVIEW;

EID: 85041091493     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.MR000039     Document Type: Article
Times cited : (33)

References (16)
  • 1
    • 84885468626 scopus 로고    scopus 로고
    • Eliciting harms data from trial participants: how perceptions of illness and treatment mediate recognition of relevant information to report
    • Allen EN, Barnes KI, Mushi AM, Massawe I, Staedke SG, Mehta U, et al. Eliciting harms data from trial participants: how perceptions of illness and treatment mediate recognition of relevant information to report. Trials 2011;12(Suppl 1):A10.
    • (2011) Trials , vol.12
    • Allen, E.N.1    Barnes, K.I.2    Mushi, A.M.3    Massawe, I.4    Staedke, S.G.5    Mehta, U.6
  • 2
    • 33644906137 scopus 로고    scopus 로고
    • Brief communication: Better ways to question patients about adverse medical events: a randomized, controlled trial
    • Bent S, Padula A, Avins AL. Brief communication: Better ways to question patients about adverse medical events: a randomized, controlled trial. Annals of Internal Medicine 2006;144(4):257-61.
    • (2006) Annals of Internal Medicine , vol.144 , Issue.4 , pp. 257-261
    • Bent, S.1    Padula, A.2    Avins, A.L.3
  • 3
    • 33745890714 scopus 로고    scopus 로고
    • Management of safety information from clinical trials. Report of CIOMS Working Group VI
    • Geneva: CIOMS
    • Council for International Organizations of Medical Sciences. Management of safety information from clinical trials. Report of CIOMS Working Group VI. Management of safety information from clinical trials. Report of CIOMS Working Group VI. Geneva: CIOMS, 2005.
    • (2005) Management of safety information from clinical trials. Report of CIOMS Working Group VI
  • 5
    • 77952197101 scopus 로고    scopus 로고
    • Reviewer guidance: Conducting a clinical sfatey review of a new product application and preparing a report on the review
    • US Food, Drug Administration. Reviewer guidance: Conducting a clinical sfatey review of a new product application and preparing a report on the review. http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation /Guidances/ucm072974.pdf 2005.
    • (2005)
  • 6
    • 79957995000 scopus 로고    scopus 로고
    • Meta-analyses of adverse effects data derived from randomised controlled trials as compared to observational studies: methodological overview
    • [PUBMED: 21559325]
    • Golder S, Loke YK, Bland M. Meta-analyses of adverse effects data derived from randomised controlled trials as compared to observational studies: methodological overview. PLoS Medicine 2011;8(5):e1001026. [PUBMED: 21559325]
    • (2011) PLoS Medicine , vol.8 , Issue.5
    • Golder, S.1    Loke, Y.K.2    Bland, M.3
  • 7
    • 0037098199 scopus 로고    scopus 로고
    • Quantifying heterogeneity in a meta-analysis
    • Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Statistics in Medicine 2002;21:1539-58.
    • (2002) Statistics in Medicine , vol.21 , pp. 1539-1558
    • Higgins, J.P.1    Thompson, S.G.2
  • 8
    • 80052145719 scopus 로고    scopus 로고
    • Checking reference lists to find additional studies for systematic reviews
    • Horsley T, Dingwall O, Sampson M. Checking reference lists to find additional studies for systematic reviews. Cochrane Database of Systematic Reviews 2011, Issue 8. [DOI: 10.1002/14651858.MR000026.pub2]
    • (2011) Cochrane Database of Systematic Reviews , Issue.8
    • Horsley, T.1    Dingwall, O.2    Sampson, M.3
  • 10
    • 0003663972 scopus 로고    scopus 로고
    • Guideline for Good Clinical Practice (Topic E6/R1)
    • International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH). Guideline for Good Clinical Practice (Topic E6/R1). http://www.ich.org/products/guidelines/efficacy/article/efficacy-guidelines.html. 1996.
    • (1996)
  • 11
    • 85041796469 scopus 로고    scopus 로고
    • Pharmacovigilance planning: notice for guidance on planning pharmacovigilance activities (Topic E2E)
    • International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH). Pharmacovigilance planning: notice for guidance on planning pharmacovigilance activities (Topic E2E). http://www.ich.org/products/guidelines/efficacy/article/efficacy-guidelines.html. 2004.
    • (2004)
  • 14
    • 0034823867 scopus 로고    scopus 로고
    • Funnel plots for detecting bias in meta-analysis: Guidelines on choice of axis
    • Sterne JAC, Egger M. Funnel plots for detecting bias in meta-analysis: Guidelines on choice of axis. Journal of Clinical Epidemiology 2001;54(10):1046-55.
    • (2001) Journal of Clinical Epidemiology , vol.54 , Issue.10 , pp. 1046-1055
    • Sterne, J.A.C.1    Egger, M.2
  • 15
    • 26944489067 scopus 로고    scopus 로고
    • Detecting treatment emergent adverse events in clinical trials: a comparison of spontaneously reported and solicited collection methods
    • Wernicke JF, Faries D, Milton D, Weyrauch K. Detecting treatment emergent adverse events in clinical trials: a comparison of spontaneously reported and solicited collection methods. Drug Safety 2005;28(11):1057-63.
    • (2005) Drug Safety , vol.28 , Issue.11 , pp. 1057-1063
    • Wernicke, J.F.1    Faries, D.2    Milton, D.3    Weyrauch, K.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.